Tess Egginton

Merck (known as MSD outside of the United States and Canada) has opened a new, $1 billion, 225,000 sq ft facility dedicated to vaccine...

Ono Pharmaceutical has entered into a license agreement with Ionis Pharmaceuticals for sapablursen, an investigational RNA-targeted medicine for the treatment of polycythemia vera (PV). Sapablursen...

ONCOVITA, a biotechnology company specializing in innovative vaccine development and a spin-off from the Institut Pasteur, and UNITHER Pharmaceuticals, a global leader in sterile...